The pathologist and the residual tumor (R) classification.
about
A uniform residual tumor (R) classification: integration of the R classification and the circumferential margin status.Concurrent chemoradiation with capecitabine and weekly irinotecan as preoperative treatment for rectal cancer: results from a phase I/II study.Intensified concurrent chemoradiotherapy with 5-fluorouracil and irinotecan as neoadjuvant treatment in patients with locally advanced rectal cancerEmerging aspects of oesophageal and gastro-oesophageal junction cancer histopathology - an update for the surgical oncologist.Impact of margin status and lymphadenectomy on clinical outcomes in resected pancreatic adenocarcinoma: implications for adjuvant radiotherapy.Role of total mesorectal excision and of circumferential resection margin in local recurrence and survival of patients with rectal carcinoma.Adjuvant therapy and survival after resection of pancreatic adenocarcinoma: a population-based analysis.Integrated imaging of non-small cell lung cancer recurrence: CT and PET-CT findings, possible pitfalls and risk of recurrence criteria.Factors influencing receipt of adjuvant chemotherapy after surgery for pancreatic cancer: a two-center retrospective cohort study.Albumin-bilirubin versus Child-Pugh score as a predictor of outcome after liver resection for hepatocellular carcinoma.Right colic artery anatomy: a systematic review of cadaveric studies.Is Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy Justified for Biphasic Variants of Peritoneal Mesothelioma? Outcomes from the Peritoneal Surface Oncology Group International Registry.Preoperative platelet-to-lymphocyte ratio is a valuable prognostic biomarker in patients with hepatocellular carcinoma undergoing curative liver resection.Pseudomyxoma peritonei: natural history and treatment.Impact of residual disease after "unplanned excision" of primary localized adult soft tissue sarcoma of the extremities: evaluation of 452 cases at a single Institution.The lymphocyte-to-monocyte ratio is a superior predictor of overall survival compared to established biomarkers in HCC patients undergoing liver resection.Adenocarcinoma of the Colon Disguised as Abdominal Wall Abscess: Case Report and Review of the Literature.
P2860
Q34609061-C71144E5-B2D2-46CA-8124-2DBFDAF4FAC7Q36614013-85E5AE71-7069-42DF-8A54-268D6938E026Q36616544-AC532544-D02C-4414-90A5-EB993296D90DQ36659456-B8A412E7-74F8-4FCA-8A1E-5BE04FB4CEC8Q36666606-D079A6AE-4491-4CD3-879E-34F95761BE01Q36769801-4FE9F72B-B850-4BD4-B304-97B4D0F576B0Q37718744-AB149D13-787E-4943-BBD5-8E218DA2ABCEQ37942070-BE238782-0305-411B-AD1B-7487146F0015Q39419609-70A4F4D8-E1C3-43EC-817D-65306D3AE8AAQ40838161-CF0E44C0-9E0C-4879-921B-65E49FF11AC3Q47120698-CB3A1317-B5CD-4052-A8A9-64EF5BE05AAAQ47279011-5DA63958-1801-4852-BE19-D8DE0821E180Q47339205-5046BEEB-C626-47A8-B3CB-80317BF0BF84Q48104553-F891750D-0DB0-4829-B240-B58EB28EAFBDQ48231545-CA77B0F2-DF0D-415F-B6C7-050A31360A26Q49301073-12799233-316A-4C21-9156-4DBD0A3DAFDEQ55375912-4C911392-E013-40F9-A7D5-7D7962BF3907
P2860
The pathologist and the residual tumor (R) classification.
description
1994 nî lūn-bûn
@nan
1994 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
1994 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
name
The pathologist and the residual tumor (R) classification.
@ast
The pathologist and the residual tumor (R) classification.
@en
The pathologist and the residual tumor
@nl
type
label
The pathologist and the residual tumor (R) classification.
@ast
The pathologist and the residual tumor (R) classification.
@en
The pathologist and the residual tumor
@nl
prefLabel
The pathologist and the residual tumor (R) classification.
@ast
The pathologist and the residual tumor (R) classification.
@en
The pathologist and the residual tumor
@nl
P1476
The pathologist and the residual tumor (R) classification.
@en
P2093
Hermanek P
Wittekind C
P304
P356
10.1016/S0344-0338(11)80700-4
P577
1994-02-01T00:00:00Z